First human tests begin for experimental Blood-Boosting drug
NCT ID NCT07429006
Summary
This is the first study to test the experimental drug AKB-9090 in humans. It aims to check if the drug is safe and how the body processes it in 70 healthy adult volunteers. Researchers will give different doses and measure drug levels and effects on markers related to red blood cell production. The main goal is to understand the drug's safety profile before testing it in people with medical conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.